Stocktoria
Burning Rock Biotech Ltd BNR
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2020-06-12
Burning Rock Biotech Ltd financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $77.2M | $70.7M | $75.7M | $81.7M | $79.7M |
| Gross profit | $57.6M | $49.6M | $51.2M | $55.1M | $57.1M |
| R&D expense | $23.8M | $31.8M | $48.9M | $61.2M | $57.7M |
| Operating income | -$7.8M | -$49.0M | -$94.3M | -$142.1M | -$125.1M |
| Interest expense | — | — | — | — | $241,000 |
| Income tax | $223,000 | $806,000 | $336,000 | $288,000 | $141,000 |
| Net income | -$7.9M | -$47.5M | -$92.1M | -$140.8M | -$125.0M |
| Operating cash flow | -$4.1M | -$12.6M | -$36.0M | -$66.2M | -$75.0M |
| Free cash flow | -$4.8M | -$13.4M | -$37.2M | -$75.2M | -$107.1M |
| Cash & equivalents | $68.4M | $71.2M | $86.6M | $131.3M | $224.6M |
| Inventory | $6.9M | $8.6M | $9.7M | $18.9M | $19.3M |
| Total assets | $117.3M | $121.3M | $146.5M | $230.2M | $357.6M |
| Total liabilities | $40.8M | $41.7M | $38.3M | $62.2M | $68.0M |
| Shareholders' equity | $76.5M | $79.6M | $108.2M | $167.9M | $289.6M |
Source: SEC EDGAR filings · CIK 0001792267 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.